BRD0705
BRD0705 is a potent, orally bioavailable small molecule inhibitor with significant selectivity for GSK3α over GSK3β. It is a valuable research tool for investigating the distinct roles of GSK3 paralogs in cellular signaling, proliferation, and in vivo models of disease.
Product Specifications
CAS Number
2056261-41-5
Product Name Alternative
β-catenin, survival, GSK-3β (WT), GSK-3α, GSK3α, GSK-3, GSK3, Glycogen synthase kinase-3, Glycogen synthase kinase 3, leukemia, Inhibitor, oral, inhibit, kinase, myeloid, BRD 0705, BRD0705, BRD-0705, bioavailability, Acute
Field of Research
Signal Transduction, Stem Cell & Developmental Biology
Purity
99.01% (May vary between batches)
Solubility
DMSO:300 mg/mL (933.36 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:5 mg/mL (15.56 mM)
Smiles
CC[C@@]1 (C2=CNNC2=NC2=C1C (=O) CC (C) (C) C2) c1ccccc1
Molecular Formula
C20H23N3O
Molecular Weight
321.42
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6256762-01 0.1 mL
CD49f (CD49f Antigen, Integrin alpha 6, ITGA6, ITGA6B, VLA 6 alpha Subunit, VLA-6) (MaxLight 750)
Sign In for Pricing
View Details MBS6256762-02 5x 0.1 mL
CD49f (CD49f Antigen, Integrin alpha 6, ITGA6, ITGA6B, VLA 6 alpha Subunit, VLA-6) (MaxLight 750)
Sign In for Pricing
View Details 